Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Lung Neoplasms 3Tobacco Use Disorder 1Smoking Cessation 1NSCLC 1Motor Activity 1Inflammation 1Adenocarcinoma of Lung 1

Interventions

Counseling 4Early Intervention, Educational 3Tobacco Use Cessation Devices 2Nicotine Replacement Therapy 2Nicotine 2Bupropion 2phenethyl isothiocyanate 1phenanthrene tetraol 1phenanthrene 1Zinc Oxide 1X-Rays 1Varenicline 1Sulindac 1Spectroscopy, Fourier Transform Infrared 1Risk Factors 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Methods 1Memantine 1Immunohistochemistry 1Gene Expression Profiling 1Focus Groups 1Fertility 1Endoscopic Mucosal Resection 1Drug Therapy 1Cognitive Behavioral Therapy 1Calcitriol 1Behavior Therapy 1Aspirin 14-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tobacco Use Disorder × Aspirin × Thoracic × Clear all
NCT02123849 2018-08-29

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

National Cancer Institute (NCI)

Phase 2 Completed
54 enrolled 15 charts
Thoracic

Lung Neoplasms, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡